CPI 203

CPI 203


CPI-203 is a primary amide analog of (+)-JQ1, which has shown superior bioavailability with oral or i.p. administration. CPI-203 downregulates Myc expression, causes G1 cell cycle arrest and attenuates cell proliferation in human pancreatic neuroendocrine tumors. CPI-203 also arrests the growth of T cell acute lymphoblastic leukemia cells in vitro (EC50 = 91.2 nM). Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.

Molecular structure of the compound BP-25351
    • Unit
    • Price
    • Qty
    • 10 MG
    • $180.00
    • 25 MG
    • $350.00
    • 50 MG
    • $525.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire